ciclazindol has been researched along with barium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiley, CR; White, R | 1 |
| Andersson, DA; Andersson, TL; Högestätt, ED; Movahed, P; Zygmunt, PM | 1 |
2 other study(ies) available for ciclazindol and barium
| Article | Year |
|---|---|
A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
Topics: 4-Aminopyridine; Animals; Apamin; Arachidonic Acids; Barium; Biological Factors; Calcium Channel Blockers; Charybdotoxin; Endocannabinoids; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; Indoles; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Peptides; Pertussis Toxin; Piperidines; Polyunsaturated Alkamides; Potassium; Potassium Channel Blockers; Protease Inhibitors; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Tosyl Compounds; Vasodilation; Virulence Factors, Bordetella | 1997 |
Effects of inhibitors of small- and intermediate-conductance calcium-activated potassium channels, inwardly-rectifying potassium channels and Na(+)/K(+) ATPase on EDHF relaxations in the rat hepatic artery.
Topics: Acetylcholine; Alkanes; Animals; Barium; Biological Factors; Calcium; Clotrimazole; Dose-Response Relationship, Drug; Electric Conductivity; Enzyme Inhibitors; Erythrocytes; Female; Hepatic Artery; Humans; In Vitro Techniques; Indoles; Ketoconazole; Ouabain; Potassium; Potassium Channel Blockers; Potassium Channels; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes; Scorpion Venoms; Sodium-Potassium-Exchanging ATPase; Tubocurarine; Vasodilation | 2000 |